Skip to content
Careers
Contact us
Our Company
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Indications
Overview
Diabetic Kidney Disease
Type 1 and Type 2 Diabetes
Non-alcoholic steatohepatitis
Lung Fibrosis
Other indications
Our Approach
Peripheral CB1 Blockade
The Endocannabinoid System
CB1 Inverse Agonists
References
Our Pipeline
Investors
News & Events
FR
EN
Menu
Home
Our Company
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Indications
Overview
Diabetic Kidney Disease
Type 1 and Type 2 Diabetes
Non-alcoholic steatohepatitis
Lung Fibrosis
Other indications
Our Approach
Peripheral CB1 Blockade
The Endocannabinoid System
CB1 Inverse Agonists
References
Our Pipeline
Investors
News & Events
Careers
Media
Contact us
Contact us
Contact us
Contact us
Please take note of our new address as of January 4, 2022
1100 René-Lévesque Blvd West
Suite 1110
Montreal, Quebec
H3B 4N4 Canada
1 438 300-2534
Loading…
